Ausgabe 4/1997
Inhalt (6 Artikel)
The Challenge of Effectively Communicating Risk-Benefit Information
I. Ralph Edwards, Bruce Hugman
Newer Anticonvulsant Drugs
Stephanie Natsch, Yechiel A. Hekster, Antoine Keyser, Charles L. P. Deckers, Harry Meinardi, Willy O. Renier
Safety Aspects of Parenteral Iron in Patients with End-Stage Renal Disease
Gere Sunder-Plassmann, Walter H. Hörl
A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression
Siegfried Kasper, Nicole Praschak-Rieder, Johannes Tauscher, Rainer Wolf